Management of Stage III melanoma has evolved in recent years. With the advent of effective adjuvant therapy in treating Stage III melanoma, sentinel node biopsy (SNB) is essential for accurate clinical decision-making for clinicians.
Join Professor Andrew Spillane for an engaging live webinar on the role of SNB, the current practice undertaken at Melanoma Institute Australia and the implications for adjuvant therapy.
Suitable for: General and Plastic Surgeons, Surgical Oncologists, Dermatologists, GPs and Nurses
PLEASE NOTE: All times are AEDT (Australian Eastern Daylight Time)